Results 251 to 260 of about 1,901,604 (311)

SJA is now on PubMed

Saudi Journal of Anaesthesia, 2010
openaire   +3 more sources

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, Elvira Bramon, Helen Cross, Natalie Curley, Sarah Curran, Helen Davies, Jana De Villiers, William Evans, Bernhard Frank, Alice Groves, Judith Hayward, Jon Higham, Dyfrig A. Hughes, Shwe Sin Kyaw, Anthony G. Marson, Ailsa McLellan, Seth Mensah, Francis O'Neill, Jane Sargison, Sanjay M. Sisodiya, Jill Swan, Joanna M. Zakrewska, Munir Pirmohamed   +24 more
wiley   +1 more source

Global trends and emerging hotspots of macrophage research in kidney transplantation: a bibliometric and visualization analysis. [PDF]

Front Immunol
Cai T, He X, Cheng S.
europepmc   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Correction: Cross-Sectional Study on Oral Nicotine Product Sales Trends in Scandinavia From 2018 to 2025. [PDF]

JMIR Public Health Surveill
Murphy MA, Henenberg D, Reese L.
europepmc   +1 more source

Indexed in Medline/PubMed

Revista Española de Cirugía Ortopédica y Traumatología (English Edition), 2013
openaire   +2 more sources

Global and regional knowledge of antibiotic use and resistance among healthcare students: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims We synthesized and analysed existing evidence on healthcare students' knowledge of antibiotic use and resistance to provide pooled global and regional estimates. Methods The PubMed®, Embase® and CINAHL databases were searched for studies published between January 2015 and October 2025 that reported the knowledge of antibiotic use and resistance ...
Asa Auta, Erick Wesley Hedima, Emmanuel O. Adewuyi, Shalkur David, Emmanuel Agada David, Lomikga Balachandran, Enoche Florence Oga, Davies Adeloye, Barry Strickland‐Hodge   +8 more
wiley   +1 more source

Summary of the best evidence for non-pharmacological interventions for dyslipidemia in patients with coronary heart disease. [PDF]

Front Cardiovasc Med
Zeng Z, Zhou X, Jiang L, Huang Y, He X, Luo H.   +5 more
europepmc   +1 more source

Correction: Transition From a Paper Diary to an Electronic Diary by Parents of Preschool Children With Food Allergies: Pilot Study. [PDF]

JMIR Form Res
Kato Y.
europepmc   +1 more source

Global Trends and Advances in Traumatic Brain Injury

Brain Health, EarlyView.
ABSTRACT Traumatic brain injury (TBI) remains a major global public health challenge, contributing substantially to morbidity and mortality while imposing a significant socioeconomic burden. In recent years, notable progress has been made in understanding TBI pathophysiology, classification, monitoring, and treatment.
Yuan Zhuang, Xixian Liao, Jiyao Jiang, Guoyi Gao   +3 more
wiley   +1 more source